MODULATION OF THE PHOSPHOINOSITIDE 3-KINASE SIGNALING PATHWAY ALTERS HOST RESPONSE TO SEPSIS, INFLAMMATION, AND ISCHEMIA/REPERFUSION INJURY

ABSTRACT The phosphoinositide 3-kinases (PI3Ks) are a conserved family of signal transduction enzymes that are involved in regulating cellular activation, inflammatory responses, chemotaxis, and apoptosis. We have discovered that a carbohydrate ligand, glucan, will stimulate the endogenous PI3K/Akt signaling pathway. This article reviews the current data on the role of the PI3K/Akt signaling pathway as a negative feedback mechanism or compensatory regulator of septic and inflammatory responses. Of greater importance, the data reviewed in this article suggest that modulation of the PI3K/Akt signaling pathway can reduce the morbidity and mortality associated with septic and I/R injury. Thus, manipulation of the endogenous PI3K/Akt signaling pathway may represent a new and novel therapeutic approach to management of important diseases.

[1]  Emilio Hirsch,et al.  Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.

[2]  D. F. Barber,et al.  PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.

[3]  J. Woodgett,et al.  GSK3: an in-Toll-erant protein kinase? , 2005, Nature Immunology.

[4]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[5]  A. Keeton,et al.  Blockade of rapid versus prolonged extracellularly regulated kinase 1/2 activation has differential effects on insulin-induced gene expression. , 2005, Endocrinology.

[6]  M. Wymann,et al.  Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. , 2005, Current opinion in cell biology.

[7]  H. Ensley,et al.  Introduction to the Chemistry and Immunobiology of _ -Glucans , 2005 .

[8]  V. Castranova,et al.  Toxicology of 1 - 3-Beta-Glucans : Glucans as a Marker for Fungal Exposure , 2005 .

[9]  S. Gordon,et al.  Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. , 2004, Blood.

[10]  E. Verrier,et al.  Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. , 2004, The Journal of thoracic and cardiovascular surgery.

[11]  M. Crackower,et al.  The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. , 2004, Journal of molecular and cellular cardiology.

[12]  Ursula Bommhardt,et al.  Akt Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis1 , 2004, The Journal of Immunology.

[13]  E. Abraham,et al.  Phosphoinositide 3-Kinase and Akt Occupy Central Roles in Inflammatory Responses of Toll-Like Receptor 2-Stimulated Neutrophils1 , 2004, The Journal of Immunology.

[14]  David L. Williams,et al.  Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection. , 2004, Cardiovascular research.

[15]  J. Kalbfleisch,et al.  Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis 1 , 2004, The Journal of Immunology.

[16]  S. Gordon,et al.  Fungal β-Glucans and Mammalian Immunity , 2003 .

[17]  S. Koyasu,et al.  PI3K and negative regulation of TLR signaling. , 2003, Trends in immunology.

[18]  J. Kalbfleisch,et al.  Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. , 2003, Critical care medicine.

[19]  J. Oyama,et al.  Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice , 2003, Circulation.

[20]  K. Vuori,et al.  Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages , 2003, European journal of immunology.

[21]  N. Mackman,et al.  The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells* , 2002, The Journal of Biological Chemistry.

[22]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[23]  Siamon Gordon,et al.  Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.

[24]  J. Kalbfleisch,et al.  Human monocyte scavenger receptors are pattern recognition receptors for (1→3)‐β‐D‐glucans , 2002, Journal of leukocyte biology.

[25]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[26]  Tsutomu Takeuchi,et al.  Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice , 2002, Nature Immunology.

[27]  L. Cantley,et al.  Phosphoinositide 3-kinase in immunological systems. , 2002, Seminars in immunology.

[28]  R. Shenkar,et al.  Involvement of Phosphoinositide 3-Kinases in Neutrophil Activation and the Development of Acute Lung Injury1 , 2001, The Journal of Immunology.

[29]  L. Moldawer,et al.  SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.

[30]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[31]  David L. Williams,et al.  Early activation of IKKβ during in vivo myocardial ischemia , 2001 .

[32]  Qingbo Xu,et al.  Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study , 2001 .

[33]  Y. Fujio,et al.  Glycoprotein 130 Regulates Cardiac Myocyte Survival in Doxorubicin-Induced Apoptosis Through Phosphatidylinositol 3-Kinase/Akt Phosphorylation and Bcl-xL/Caspase-3 Interaction , 2001, Circulation.

[34]  Ping H Wang,et al.  Expression of Constitutively Active Phosphatidylinositol 3-Kinase Inhibits Activation of Caspase 3 and Apoptosis of Cardiac Muscle Cells* , 2000, The Journal of Biological Chemistry.

[35]  P. Godowski,et al.  Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway , 2000, Nature Immunology.

[36]  D. Cucinotta,et al.  IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. , 2000, Cardiovascular research.

[37]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[38]  G. Gross,et al.  The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. , 2000, Journal of molecular and cellular cardiology.

[39]  J. Kalbfleisch,et al.  inhibition Of Lps-induced Nfκb Activation By A Glucan Ligand Involves Down-regulation Of Ikkβ Kinase Activity And Altered Phosphorylation And Degradation Of Iκbα , 2000 .

[40]  S. Cuzzocrea,et al.  Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[41]  V. Thourani,et al.  Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury. , 2000, American journal of physiology. Heart and circulatory physiology.

[42]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[43]  Silvano Sozzani,et al.  Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .

[44]  L. Dekker,et al.  Signals to Move Cells , 2000, Science.

[45]  R. Kao,et al.  Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart. , 2000, Surgery.

[46]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[47]  R. Hajjar,et al.  Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. , 1999, Circulation.

[48]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[49]  J. Kalbfleisch,et al.  Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D -glucan increases long-term survival in polymicrobial sepsis , 1999 .

[50]  R. Kao,et al.  Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[51]  D. Melican,et al.  Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. , 1998, International journal of immunopharmacology.

[52]  B. Bozkurt,et al.  The role of cytokines in the failing human heart. , 1998, Cardiology clinics.

[53]  A. Toker,et al.  Phosphatidylinositol 3‐kinase is recruited to a specific site in the activated IL‐1 receptor I , 1998, FEBS letters.

[54]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[55]  R. Peshock,et al.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. , 1998, Circulation.

[56]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[58]  Y. Kaneda,et al.  A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. , 1997, Circulation.

[59]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[60]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[61]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[62]  David L. Williams,et al.  Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. , 1996, Journal of immunology.

[63]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[64]  S. Hagen,et al.  Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). , 1996, Journal of molecular and cellular cardiology.

[65]  H. Oral,et al.  Tumor necrosis factor-alpha and the failing human heart. , 1995, Clinical cardiology.

[66]  H. Oral,et al.  Tumor necrosis factor‐α and the failing human heart–TNFα and heart failure , 1995 .

[67]  L. Moldawer,et al.  BLOCKADE OF TUMOR NECROSIS FACTOR REDUCES LIPOPOLYSACCHARIDE LETHALITY, BUT NOT THE LETHALITY OF CECAL LIGATION AND PUNCTURE , 1995, Shock.

[68]  O. Hazeki,et al.  Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. , 1995, Trends in biochemical sciences.

[69]  K. Mcdonough,et al.  EFFECTS OF SEPSIS ON RECOVERY OF THE HEART FROM 50 MIN ISCHEMIA , 1994, Shock.

[70]  W. Barry.  Mechanisms of immune-mediated myocyte injury. , 1994, Circulation.

[71]  G. Gross,et al.  Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. , 1993, Cardiovascular research.

[72]  A. Harken,et al.  Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Adi,et al.  Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin. , 2001, Endocrinology.

[74]  S. Adi,et al.  Growth Factor-Stimulated Phosphorylation of Akt and p70S6K Is Differentially Inhibited by LY294002 and Wortmannin. , 2001, Endocrinology.

[75]  L. Dekker,et al.  Perspectives: signal transduction. Signals to move cells. , 2000, Science.

[76]  D. Ganten,et al.  NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. , 2000, Hypertension.

[77]  C. Garlanda,et al.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. , 2000, Science.

[78]  D. Ganten,et al.  NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats , 2000 .

[79]  G. Freeman,et al.  Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. , 1998, Biochimica et biophysica acta.

[80]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[81]  D. Mann,et al.  Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. , 1996, Circulation.